Bleeding on HRT: What Is Normal, What Is Not, and When to Call Your Doctor

You started hormone therapy to feel better, and for the most part you do. The hot flashes have eased, you are sleeping again, the fog is lifting. And then one morning there is spotting, or an unexpected bleed, and a cold thread of worry runs through you. Is something wrong? Should you stop?

Unexpected bleeding is the single most common reason women abandon hormone therapy, and that is a shame, because the great majority of the time it is harmless, expected, and temporary. But not always. Some bleeding genuinely needs to be evaluated. The goal of this article is to help you tell the difference, understand what your specific regimen has to do with it, and know exactly when to pick up the phone.

First, the reassuring context

When you add estrogen back into the body, it acts on the lining of the uterus, the endometrium. If you still have a uterus, your regimen also includes a progestogen (progesterone or a synthetic progestin) specifically to keep that lining thin and protected. The interplay between these two hormones, and the particular schedule your provider chose, is what determines whether and when you bleed. Most bleeding on hormone therapy is simply the lining adjusting to this new hormonal input. It is mechanical and hormonal, not a sign of danger in itself.

That said, the uterus has a limited vocabulary. It signals almost everything, including the rare problem that matters, the same way: with bleeding. That is precisely why certain patterns should always be checked, even though most turn out to be nothing. Caution here is not alarmism. It is good medicine.

What your regimen tells you to expect

The kind of bleeding that is considered normal depends heavily on which type of regimen you are on. There are two broad approaches.

Cyclic (sequential) therapy

With cyclic therapy, you take estrogen continuously and add the progestogen for only part of the month, often twelve to fourteen days. This schedule is common in perimenopause and early menopause. On this regimen, a predictable monthly bleed, similar to a light period, arriving around the time you stop or finish the progestogen each cycle, is completely expected. It is sometimes called a withdrawal bleed. Many women on cyclic therapy will have this scheduled bleeding, and it is not a cause for concern as long as it is regular and predictable.

Continuous combined therapy

With continuous combined therapy, you take both estrogen and progestogen every day, with no break. The goal of this regimen is no bleeding at all over time. But here is the part that trips women up: in the first three to six months, irregular spotting and breakthrough bleeding are extremely common and entirely expected as the lining stabilizes and becomes thin and quiet. This early unpredictable spotting is not a red flag. It is the normal settling-in process. Studies consistently show that the majority of women on continuous combined therapy become bleed-free within six months to a year.

The honest timeline: when spotting is normal

Putting it together, here is the pattern that should reassure rather than worry you:

The first 3 to 6 months of continuous combined therapy. Light, irregular spotting or breakthrough bleeding during this window is the expected adjustment phase. Tracking it, noting the days and how heavy, is useful, but it usually does not mean anything is wrong.

Predictable monthly bleeding on a cyclic regimen. Regular, period-like bleeding that arrives on schedule each cycle is the designed behavior of that regimen.

Spotting after a missed or late dose. Hormone levels dipping because of a skipped patch, pill, or gel can trigger a small bleed. Getting back on a consistent schedule usually settles it.

When to call your provider

Now the part that matters most. Some bleeding always warrants a call, not because it is usually serious, but because the only way to be sure it is harmless is to have it evaluated. Contact your provider if you experience any of the following:

New bleeding after you have been bleed-free. If you were settled and not bleeding for several months or longer on continuous therapy, and bleeding starts again, that change deserves evaluation.

Heavy bleeding, soaking through pads, passing clots, or bleeding that feels like a heavy period when none was expected.

Bleeding that persists beyond six months on a continuous combined regimen, rather than tapering off as the lining stabilizes.

Bleeding that is irregular or unpredictable on a cyclic regimen, especially bleeding that happens at a different time than your expected scheduled bleed, or between cycles.

Any bleeding accompanied by pain, unusual discharge, or bleeding after intercourse.

For women who are fully postmenopausal and not on hormone therapy at all, the rule is even simpler and worth stating clearly: any vaginal bleeding after menopause should always be reported to a provider. It is most often caused by something benign such as thin tissue, but it is the symptom that must never be ignored.

What evaluation usually involves

If you do need to be checked, the workup is typically straightforward and not something to dread. Your provider will likely start with a transvaginal ultrasound to measure the thickness of the endometrial lining. A thin lining is very reassuring. If the lining is thicker than expected, or the bleeding pattern is concerning, the next step is often an endometrial biopsy, a quick office procedure that samples the lining to rule out abnormal cells. In some cases a hysteroscopy, where a thin camera looks directly inside the uterus, is used. The overwhelming majority of these evaluations find a benign cause: the lining adjusting, a small polyp, or simple atrophy.

Adjusting the regimen instead of quitting

Here is what I most want you to take away. If bothersome bleeding is making you want to stop hormone therapy, talk to your provider before you do. There is almost always an adjustment that helps: changing the type or dose of progestogen, switching from cyclic to continuous, changing the delivery method, or simply confirming with a quick ultrasound that everything is healthy and waiting out the adjustment window. Stopping therapy because of bleeding means giving up the symptom relief you worked to get, often unnecessarily. A provider who manages hormone therapy regularly will have seen this many times and will have practical options.

"Most bleeding on hormone therapy is the lining settling in, not a warning sign. But the only way to turn worry into certainty is to have the patterns that matter checked. Track it, and never feel you are overreacting by asking."

Medical Disclaimer: This article is for general educational purposes only and is not medical advice. Bleeding patterns on hormone therapy are individual, and any unexpected or postmenopausal bleeding should be evaluated by a qualified healthcare provider. Always consult your provider about your specific symptoms and regimen.